T. Rowe Price Expands Claude Across Investment Teams and Developers35m ago Val Bercovici, Chief AI Officer at WEKA – Interview Series43m ago Ben Jennings on the Bayeux tapestry – cartoon43m ago The latest Avatar: Seven Havens trailer gives us a deeper dive into the characters and story44m ago Agentic AI Is The New Attack Surface: How Can SAP Application Security Teams Repel It?45m ago Pony.ai Starts Fully Driverless Robotaxi Passenger Tests in Zagreb46m ago Euno raises $23m to give enterprise AI agents the context they lack48m ago Nvidia’s Huang Touts Cybersecurity as Next Big Market for AI52m ago Universal Music is launching an AI music platform with ElevenLabs58m ago Red Hat AI 3.5 tackles the GPU queue that can stall AI pilots59m ago Moonshot Secretly Routed User Requests Through Claude, Anthropic Says1h ago A Candid Abacus AI Review: The All-in-One AI Platform for Professionals & Enterprises1h ago Governments are turning to Claude to automate spying1h ago Anthropic Says It Blocked Possible Efforts to Build Biological Weapons1h ago

T. Rowe Price Expands Claude Across Investment Teams and Developers35m ago Val Bercovici, Chief AI Officer at WEKA – Interview Series43m ago Ben Jennings on the Bayeux tapestry – cartoon43m ago The latest Avatar: Seven Havens trailer gives us a deeper dive into the characters and story44m ago Agentic AI Is The New Attack Surface: How Can SAP Application Security Teams Repel It?45m ago Pony.ai Starts Fully Driverless Robotaxi Passenger Tests in Zagreb46m ago Euno raises $23m to give enterprise AI agents the context they lack48m ago Nvidia’s Huang Touts Cybersecurity as Next Big Market for AI52m ago Universal Music is launching an AI music platform with ElevenLabs58m ago Red Hat AI 3.5 tackles the GPU queue that can stall AI pilots59m ago Moonshot Secretly Routed User Requests Through Claude, Anthropic Says1h ago A Candid Abacus AI Review: The All-in-One AI Platform for Professionals & Enterprises1h ago Governments are turning to Claude to automate spying1h ago Anthropic Says It Blocked Possible Efforts to Build Biological Weapons1h ago

Healthcare AI Research6 min reading time

Anthropic wants to develop its own drugs

The VergePublished Jul 3, 2026

Anthropic introduced Claude Science, an AI platform integrating tools and data for scientific research, and announced plans to develop drugs targeting neglected diseases. This marks a rare move for a major AI company to directly engage in drug development, alongside its existing biotech customers.

More on this story

Anthropic’s Claude Science bets on workflow, not a new model, to win over scientists
Jun 30· 2 sources

#anthropic #biotech #claude-science #drug-development #neglected-diseases #pharma

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources19h ago

Healthcare5 min read

Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes1h ago

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News2h ago